Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
  1. 4 Open-market buy Chief Financial Officer bought 14,500 shares at $6.85 ($99,325)
  2. 4 Open-market buy 10% owner bought 153,000 shares at $6.52 ($997,728)
  3. 4 Option exercise Chief Operating Officer acquired 250,000 shares (option exercise)
  4. 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
  5. 4 Option exercise Chief Financial Officer acquired 50,000 shares (option exercise)
  6. 4 Open-market buy 10% owner bought 85,102 shares at $10.10 ($859,249)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
  15. 4 Gift 10% owner gave 70,000 shares (gift)
  16. 4 Open-market buy 10% owner bought 200,000 shares at $11.46 ($2,292,460)
  17. 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
  18. 4 Open-market buy 10% owner bought 64,088 shares at an average $8.03 ($514,908)
  19. 4 Open-market buy 10% owner bought 64,545 shares at $7.50 ($483,965)
  20. 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)

Page 4 of 8 · 145 filings